Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality: Results from a Randomized Controlled Trial of ACE Inhibitors.
Toshiaki OhkumaKatie HarrisMark CooperDiederick E GrobbeePavel HametStephen HarrapGiuseppe ManciaMichel MarreAnushka PatelAnthony RodgersBryan WilliamsMark WoodwardJohn Chalmersnull nullPublished in: Clinical journal of the American Society of Nephrology : CJASN (2022)
Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE), NCT00145925.